B
Bullisch
Bullisch · 25%CLBT
$24.00
Szenariopreis
$11.370
+0.230 (+2.02%)Zum Schluss
Loading chart…
- Hoch
- 11.430
- Eröffnung
- 11.240
- Volumengewichteter Durchschnittskurs
- 11.31
- Volumen
- 1.27M
- Marktkap.
- 2.43B
- Tief
- 11.125
- Umsatz
- 14.40M
- EV/EBITDA, TTM
- 46.95
Cellebrite DI Ltd is an Israel-based company engaged primarily in the software sector. The Company is committed to providing a Digital Intelligence (DI) platform for managing DI in legally sanctioned investigations. The Company provides solutions for the public and private sectors, enabling organizations in mastering the complexities of legally sanctioned digital investigations by streamlining intelligence processes. The Company's platform and solutions transform how customers collect, review, analyze and manage data in legally sanctioned investigations. The Company aims to enable its customers to protect and save lives, accelerate justice, and preserve privacy in communities around the world.
KI-Analyse of Cellebrite DI Ltd (CLBT)
HaltenCellebrite DI Ltd is not a strong buy right now due to its current price of $11.03, which is significantly below the average analyst price target of $20. However, the stock has shown a 21% year-over-year growth in annual recurring revenue, indicating potential for recovery. The main risk is the recent earnings miss with an EPS surprise of -44.44%, suggesting that the company's financial performance may not meet investor expectations in the near term.
Bewertungskennzahlen
Das aktuelle erwartete KGV von Cellebrite DI Ltd (CLBT) beträgt 35.71, verglichen mit dem 5-Jahres-Durchschnitt von 41.20.
Alphio-AI-Kursszenarien für CLBT
Szenariopreise sind das letzte monatliche Prognoseband des laufenden Jahres. Die Wahrscheinlichkeiten sind feste Modellgewichte (25 / 50 / 25), keine Garantien.
Whales, die CLBT halten
Event-Zeitleiste
News
9.510-20PRnewswireCellebrite to Report Q3 2026 Financial Results on November 12
9.510-20PRnewswireCellebrite to Release Q3 2026 Financial Results on November 12
9.510-20PRnewswireCellebrite to Release Q3 2026 Financial Results
9.510-20PRnewswireCellebrite to Release Q3 2026 Financial Results on November 12
6.510-17FoolStocks Investors Should Consider Selling Now
CLBT FAQ – beantwortet von Alphio AI
Cellebrite DI Ltd is an Israel-based company engaged primarily in the software sector. The Company is committed to providing a Digital Intelligence (DI) platform for managing DI in legally sanctioned investigations. The Company provides solutions for the public and private sectors, enabling organizations in mastering the complexities of legally sanctioned digital investigations by streamlining intelligence processes. The Company's platform and solutions transform how customers collect, review, analyze and manage data in legally sanctioned investigations. The Company aims to enable its customers to protect and save lives, accelerate justice, and preserve privacy in communities around the world. It operates in the Technology sector.
Cellebrite DI Ltd is not a strong buy right now due to its current price of $11.03, which is significantly below the average analyst price target of $20. However, the stock has shown a 21% year-over-year growth in annual recurring revenue, indicating potential for recovery. The main risk is the recent earnings miss with an EPS surprise of -44.44%, suggesting that the company's financial performance may not meet investor expectations in the near term.
Community
Mehr ↗Noch keine Beiträge
Registriere dich oder melde dich an, um mitzudiskutierenDiese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.